200 related articles for article (PubMed ID: 16247658)
1. Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.
Yonemura Y; Endo Y; Tabata K; Kawamura T; Yun HY; Bandou E; Sasaki T; Miura M
Int J Clin Oncol; 2005 Oct; 10(5):318-27. PubMed ID: 16247658
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
3. Potential role for vascular endothelial growth factor-D as an autocrine factor for human gastric carcinoma cells.
Tanaka M; Kitadai Y; Kodama M; Shinagawa K; Sumida T; Tanaka S; Oue N; Yasui W; Chayama K
Cancer Sci; 2010 Oct; 101(10):2121-7. PubMed ID: 20626397
[TBL] [Abstract][Full Text] [Related]
4. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
[TBL] [Abstract][Full Text] [Related]
5. DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer.
Matsumura S; Oue N; Mitani Y; Kitadai Y; Yasui W
Int J Cancer; 2007 Apr; 120(8):1689-95. PubMed ID: 17230534
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
8. New model of in-situ xenograft lymphangiogenesis by a human colonic adenocarcinoma cell line in nude mice.
Sun JJ; Jing W; Ni YY; Yuan XJ; Zhou HH; Fan YZ
Asian Pac J Cancer Prev; 2012; 13(6):2823-8. PubMed ID: 22938466
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma.
Shida A; Fujioka S; Kobayashi K; Ishibashi Y; Nimura H; Mitsumori N; Yanaga K
Int J Clin Oncol; 2006 Feb; 11(1):38-43. PubMed ID: 16508727
[TBL] [Abstract][Full Text] [Related]
12. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
14. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
15. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
16. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
[TBL] [Abstract][Full Text] [Related]
17. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer.
Yonemura Y; Fushida S; Bando E; Kinoshita K; Miwa K; Endo Y; Sugiyama K; Partanen T; Yamamoto H; Sasaki T
Eur J Cancer; 2001 May; 37(7):918-23. PubMed ID: 11313181
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice.
Watanabe M; Takahashi Y; Ohta T; Mai M; Sasaki T; Seiki M
Cancer; 1996 Apr; 77(8 Suppl):1676-80. PubMed ID: 8608561
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K
J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities].
Wang KF; Ye SL; Song LJ; Weng YQ; Liang CM; Zhao Y; Gao DM; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):187-91. PubMed ID: 16556412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]